IRIS UniCatt

Pagano, Livio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.793
NA - Nord America 8.238
AS - Asia 4.155
SA - Sud America 500
AF - Africa 66
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 8
Totale 21.779
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.126
DE - Germania 3.256
SG - Singapore 1.589
CN - Cina 1.505
SE - Svezia 1.496
IT - Italia 942
UA - Ucraina 816
IE - Irlanda 517
FR - Francia 496
BR - Brasile 423
ID - Indonesia 335
IN - India 329
GB - Regno Unito 283
RU - Federazione Russa 249
FI - Finlandia 234
PL - Polonia 168
TR - Turchia 118
NL - Olanda 71
HK - Hong Kong 54
CA - Canada 51
AT - Austria 49
JP - Giappone 48
MX - Messico 46
BE - Belgio 42
ES - Italia 32
AR - Argentina 21
RO - Romania 21
CZ - Repubblica Ceca 20
IL - Israele 20
CI - Costa d'Avorio 19
CH - Svizzera 17
AU - Australia 16
IQ - Iraq 16
CL - Cile 13
TH - Thailandia 13
VN - Vietnam 13
BD - Bangladesh 12
LT - Lituania 12
PK - Pakistan 12
EC - Ecuador 11
MA - Marocco 11
CO - Colombia 10
HU - Ungheria 10
ZA - Sudafrica 10
IR - Iran 9
KR - Corea 9
KZ - Kazakistan 9
VE - Venezuela 9
GR - Grecia 8
PE - Perù 8
SA - Arabia Saudita 8
DK - Danimarca 7
EU - Europa 7
LV - Lettonia 7
UZ - Uzbekistan 7
AM - Armenia 6
EG - Egitto 6
JO - Giordania 6
PA - Panama 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
HR - Croazia 5
MD - Moldavia 5
NO - Norvegia 5
AL - Albania 4
KE - Kenya 4
LA - Repubblica Popolare Democratica del Laos 4
MY - Malesia 4
NG - Nigeria 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BO - Bolivia 3
DZ - Algeria 3
LK - Sri Lanka 3
ME - Montenegro 3
NP - Nepal 3
NZ - Nuova Zelanda 3
TN - Tunisia 3
TW - Taiwan 3
BY - Bielorussia 2
EE - Estonia 2
ET - Etiopia 2
GH - Ghana 2
IS - Islanda 2
MK - Macedonia 2
PS - Palestinian Territory 2
PY - Paraguay 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GT - Guatemala 1
KG - Kirghizistan 1
LU - Lussemburgo 1
MT - Malta 1
NI - Nicaragua 1
Totale 21.774
Salva come PNG Salva come JPEG
Città #
Chandler 1.635
Singapore 857
Ashburn 624
Jacksonville 527
Dublin 510
San Mateo 403
Jakarta 334
Ann Arbor 312
Wilmington 282
Nanjing 277
Dearborn 219
Milan 195
Nürnberg 186
Hyderabad 183
Woodbridge 182
Boston 181
Moscow 178
Houston 177
New York 173
Lawrence 170
Beijing 168
Bremen 158
Hangzhou 154
Warsaw 148
Cattolica 129
Zhengzhou 117
Rome 111
Munich 103
Princeton 103
Chicago 99
Nanchang 91
Redwood City 88
Marseille 87
Los Angeles 84
Seattle 84
Fairfield 78
Izmir 77
Boardman 69
Redmond 69
Mountain View 60
Shenyang 60
Hebei 58
Kunming 52
Nuremberg 52
Frankfurt am Main 51
Hong Kong 50
Shanghai 49
Tianjin 46
Lancaster 45
Norwalk 45
Changsha 44
University Park 43
São Paulo 41
The Dalles 41
Brussels 40
Jiaxing 38
Leawood 34
Helsinki 33
Cambridge 32
Guangzhou 32
Philadelphia 31
Washington 31
Düsseldorf 30
Toronto 27
Henderson 25
Paris 25
Auburn Hills 23
Falls Church 22
Fremont 22
Hefei 20
Lauterbourg 20
Pune 20
Andover 19
Cuauhtémoc 19
Falkenstein 19
Abidjan 18
Jinan 18
Mexico City 18
Vienna 18
Busto Arsizio 17
Florence 17
Portsmouth 17
Tokyo 17
Augusta 16
London 16
Phoenix 15
Rio de Janeiro 15
Edinburgh 14
Simi Valley 14
Lappeenranta 13
Santa Clara 12
Changchun 11
Costa Mesa 11
Council Bluffs 11
Indiana 11
Kraków 11
Monmouth Junction 11
Madrid 10
Ningbo 10
Verona 10
Totale 11.272
Salva come PNG Salva come JPEG
Nome #
Incidence of acute myeloid leukemia after breast cancer 338
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 317
Factors associated with mortality in bacteremic patients with hematologic malignancies. 309
Factors associated with mortality in bacteremic patients with haematologic malignancies 307
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 303
A prospective survey of febrile events in hematological malignancies 262
Therapy-related leukemias and myelodysplasia : susceptibility and incidence. 224
A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature 211
Factors associated with mortality in bacteremic patients with hematologic malignancies. 176
Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin 171
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 168
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay 152
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 152
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 145
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. 141
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 139
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 134
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 132
Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases 132
Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome 131
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 126
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 125
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 124
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 124
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 123
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 123
Primary plasma cell leukemia followed by testicular plasmacytoma 117
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 115
All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients 115
Epigenetic changes in therapy-related MDS/AML 114
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 114
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 113
5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature 113
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 113
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 113
Adjuvant therapy with rhGM-CSF for the treatment of Blastoschizomyces capitatus systemic infection in a patient with acute myeloid leukemia 112
Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency 112
Similarities and differences between therapy-related and elderly acute myeloid leukemia 111
Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto SCTsuccessfully treated with combination treatment. 110
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 109
A prospective survey of febrile events in hematological malignancies 108
Hyperleukocytosis and leukostasis: management of a medical emergency 107
A prospective survey of febrile events in hematological malignancies 106
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 106
Hyperleukocytosis and leukostasis: management of a medical emergency 106
Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report 106
Hema e-Chart: Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies 105
Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol. 104
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 103
Serum beta 2 microglobulin in psoriasis and psoriatic patients 102
Immature platelet fraction (IPF) in hospitalized patients with neutrophilia and suspected bacterial infection 102
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 102
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 102
A patient with acute myeloid leukemia and a solid mass in the colon. 101
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 101
Outcome of therapy-related myeloid neoplasms treated with azacitidine 98
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 98
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 98
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study 97
Uncommon yeast infections in hematological patients: from diagnosis to treatment 97
Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report. 96
ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients 96
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 96
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients 95
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 94
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 94
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 93
Scedosporiosis in patients with acute leukemia: a retrospective multicenter report 92
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 91
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 91
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients 91
Advanced mast cell disease: an Italian Hematological Multicenter experience. 90
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 90
Caspofungin for the treatment of candidaemia in patients with haematological malignancies 89
Tunneling Schmorl?s Nodes in an Elderly Woman Treated for Acute Lymphoblastic Leukemia. 88
High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma. 88
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 88
Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches 86
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 85
In vitro susceptibility of Candida species isolated from patients with haematological malignancies 85
First case of breakthrough pneumonia due to Aspergillus nomius in a patient with acute myeloid leukemia 84
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 84
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 84
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 82
A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients 82
SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders 82
Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party 82
Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule 81
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 81
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 80
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 78
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 77
Uncommon mold infections in hematological patients: epidemiology, diagnosis and treatment 76
The role of primary antifungal prophylaxis in patients with haematological malignancies 76
Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey 76
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient With Unusual Extramedullary Presentation of Recurrent Multiple Myeloma 76
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 75
Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL) 75
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 75
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) 75
Totale 11.818
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.296
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.296
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020460 0 0 0 0 0 0 0 0 0 0 209 251
2020/20211.862 97 208 44 181 241 125 247 52 220 72 348 27
2021/20222.205 260 151 34 88 149 76 33 334 115 156 332 477
2022/20234.610 525 562 397 773 365 588 167 373 561 94 158 47
2023/20242.512 126 738 92 81 95 351 203 51 36 91 302 346
2024/20253.716 168 166 398 190 445 150 228 265 960 651 95 0
Totale 22.140